At close: December 20 at 4:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-4,073.5390
-4,542.9100
-1,009.9800
-649.1060
-167.2990
Investing Cash Flow
-1,953.5780
-115.8880
-60.1330
-35.3920
-70.9780
Financing Cash Flow
7,052.5980
6,474.5650
1,221.7060
611.2260
277.3570
End Cash Position
3,244.0210
2,142.4850
264.8650
115.3990
191.7020
Income Tax Paid Supplemental Data
--
1.0000
1.0000
0.7500
1.2500
Interest Paid Supplemental Data
--
179.1170
2.1930
--
--
Capital Expenditure
-245.5780
-115.8880
-60.1330
-35.3920
-70.9780
Issuance of Capital Stock
7,144.6850
6,454.3250
--
--
--
Issuance of Debt
--
650.0000
1,105.0000
683.2260
428.5000
Repayment of Debt
--
-1,611.1110
--
-72.0000
-151.1430
Free Cash Flow
-4,319.1170
-4,658.7980
-1,070.1130
-684.4980
-238.2770
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LIXTW Lixte Biotechnology Holdings, Inc.
0.0359
+66.98%
APLMW Apollomics, Inc.
0.0125
+13.64%
NAMSW NewAmsterdam Pharma Company N.V.
14.10
+2.84%
SLXNW Silexion Therapeutics Corp
0.0249
-30.83%
HUMAW Humacyte, Inc.
1.7400
+39.20%
BVNRY Bavarian Nordic A/S
8.96
+0.45%
RVPHW Reviva Pharmaceuticals Holdings, Inc.
0.1375
-8.33%
CELZ Creative Medical Technology Holdings, Inc.
2.0700
+3.50%
CMND Clearmind Medicine Inc.
1.2000
+0.84%
LIXT Lixte Biotechnology Holdings, Inc.
1.9800
+3.13%